Rapid Non-Invasive Brain Stimulation for Hoarding Disorder
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: MagPro X100 by MagVenture.
- Who it may be relevant to
- Registry conditions: Hoarding Disorder, Hoarding, Clutter. Basic parameters: 18 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study explores whether rapid non-invasive brain stimulation can help reduce hoarding disorder symptoms.
Detailed description
Hoarding disorder (HD) is characterized by difficulty letting go of possessions, leading to clutter that congests living spaces and impairs daily functioning. The majority of HD patients treated with cognitive behavioral therapy for HD usually experience considerable residual symptoms. New treatments are greatly needed. This study explores whether rapid non-invasive brain stimulation can help reduce hoarding disorder symptoms.
Interventions
- Device MagPro X100 by MagVenture
Participants will receive 5 session per day of TBS for 6 days (30 sessions total). Six treatment days have to occur within a 2 week period. Each session will be comprised of 1800 pulses, using a MagVenture MagPro X100.
Primary outcome measures
- Change in Compulsive Acquisition Scale (CAS) [Time frame: Change from baseline to 3 weeks after treatment starts]
Eligibility criteria
Inclusion criteria
- Age 18-70 years
- Primary diagnosis of hoarding disorder
- Sufficient severity of hoarding symptoms
- Willing and able to understand and complete consent and study procedures
Exclusion criteria
- Psychiatric or medical conditions or medications that make participation unsafe
- Pregnant or nursing females
- Previous exposure to TMS or ECT
- History of any implanted device or psychosurgery
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Stanford University Medical Center — Palo Alto
Identifiers
NCT: NCT06712914 · 77098